{"entity":{"id":"nct06483100","kind":"trial","name":"Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance","aka":[],"tldr":"A phase 2 trial of clonoSEQ in Multiple myeloma, run by Washington University School of Medicine, now recruiting.","summary":"Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance is a phase 2 interventional study registered as NCT06483100 by Washington University School of Medicine, with 65 participants planned, started 2024-12-20 and due to reach its primary completion in 2032-06-30. Interventions recorded: Elrantamab, clonoSEQ. Conditions recorded: Multiple Myeloma.\n\nLinked to the drug clonoSEQ because the registry names it among its interventions and Multiple myeloma among its conditions. Registry record only: no result has been read by an editor.","status":"recruiting","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT06483100","url":"https://clinicaltrials.gov/study/NCT06483100"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["multiple-myeloma"],"sections":[],"technologies":[],"targets":[],"drugs":["clonoseq"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06483100","phase":"2","setting":"Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance","sponsor":"Washington University School of Medicine","participation":[{"nct":"NCT06483100","source":"https://clinicaltrials.gov/study/NCT06483100","fetchedAt":"2026-10-07T16:54:43.174Z","studySha256":"27f717b013afc642f6520ea4f55d06be8fe0b580fd39c14f09498e4386439fde","overallStatus":"RECRUITING","lastUpdatePosted":"2026-08-06","leadSponsor":"Washington University School of Medicine","collaboratorCount":2,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":65,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["United States"]}],"started":"2024-12-20","startedType":"actual","enrolled":65,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06483100/","neighbours":{"cancer":[{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"}],"drug":[{"id":"clonoseq","kind":"drug","name":"clonoSEQ","route":"/drugs/clonoseq/"}]}}